[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 4, 1983

Pyridostigmine Bromide and Constipation in Parkinson's Disease

Author Affiliations

Midland, Mich

JAMA. 1983;249(9):1148. doi:10.1001/jama.1983.03330330030012

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.—  It is well known that in Parkinson's disease, motility of the bowels is severely impaired in conjunction with reduced motility throughout. In patients who have advanced Parkinson's disease, severe constipation is often a major problem. This constipation is not sufficiently responsive to bulk laxatives, since such laxatives do not have a direct effect on intestinal motility.I have used pyridostigmine bromide for a number of years for patients who are not relieved by ordinary measures used against constipation. This drug, which is used in the treatment of myasthenia gravis, enhances intestinal motility and may in fact produce diarrhea and abdominal cramps in some patients and in large doses.I have not encountered any adverse effect on Parkinson's disease by use of this drug. No interaction with other drugs used for the treatment of Parkinson's disease or reduced effectiveness of such drugs has been observed. The dose of

×